Xencor

Xencor Provides Protein Engineering Technology Platform for the Biotechnology Industry, Developing Superior Monoclonal Antibody Therapies for the Treatment of Autoimmune Diseases, Asthma, Allergic Diseases, and Cancer. Xencor has also Discovered Biologics that Improve the Performance of Older Antibody Drugs, Known as "Bio-better Drugs," Which Can Benefit Patients, Reduce Compliance Burdens, and Help Lower Costs.